Risk Factors of Venous Thromboembolism in Sudanese Pregnant Women.
Deep vein thrombosis (DVT)
Factor V Leiden (FVL)
Protein C (PC)
Protein S (PS)
Prothrombin G20210A polymorphism
Journal
Balkan journal of medical genetics : BJMG
ISSN: 1311-0160
Titre abrégé: Balkan J Med Genet
Pays: Poland
ID NLM: 9806959
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
entrez:
17
10
2022
pubmed:
18
10
2022
medline:
18
10
2022
Statut:
epublish
Résumé
Venous thromboembolism (VTE) is one of the major causes of pregnancy-related mortality and morbidity. This study aimed to determine the frequency of factor V Leiden (FVL) and prothrombin G20210A polymorphisms and measure the plasma levels of protein C (PC), protein S (PS) and antithrombin (AT) in pregnant women with VTE and healthy pregnant women. This prospective case-control study determined the frequencies of FVL G1691A and prothrombin G20210A polymorphisms and measured the plasma levels of PC, PS and AT in 198 pregnant women with VTE and 198 healthy pregnant women. Allele-specific polymerase chain reaction (ASPCR) was used to detect the FVL G1691A polymorphisms and prothrombin G20210A gene mutations. The FVL G1691A polymorphism and prothrombin G20210A gene mutations were detected only in pregnant women with VTE, with frequencies of 4.0 and 0.5%, respectively. The highest frequency of FVL G1691A polymorphism was observed in patients with deep vein thrombosis (DVT) and positively associated with contraceptive use and termination. Pregnant women with VTE had significantly lower levels of PC, PS and AT than those of controls. In conclusion, among the VTE cases, FVL G1691A polymorphism and PC, PS and AT deficiencies were the most common findings in patients presenting with DVT. Antithrombin deficiency was more common than PC and PS deficiencies. Contraceptive use, high body mass index (BMI) and termination correlated strongly with FVL G1691A polymorphism and PC and PS deficiencies in patients with VTE.
Identifiants
pubmed: 36249520
doi: 10.2478/bjmg-2021-0018
pii: bjmg-2021-0018
pmc: PMC9524171
doi:
Types de publication
Journal Article
Langues
eng
Pagination
49-54Informations de copyright
© 2021 EK Abdalhabib et al., published by Sciendo.
Références
Eur J Intern Med. 2016 Jul;32:53-9
pubmed: 26972931
Balkan J Med Genet. 2016 Aug 2;19(1):43-50
pubmed: 27785407
J Clin Med. 2020 Apr 02;9(4):
pubmed: 32252449
Curr Vasc Pharmacol. 2016;14(4):368-73
pubmed: 26517701
QJM. 2006 May;99(5):289-98
pubmed: 16613994
BJOG. 2008 Mar;115(4):453-61
pubmed: 18201281
Genet Med. 2011 Jan;13(1):1-16
pubmed: 21116184
J Thromb Haemost. 2005 May;3(5):949-54
pubmed: 15869590
Curr Res Transl Med. 2020 Apr;68(2):77-80
pubmed: 31501046
Support Cancer Ther. 2006 Jan 1;3(2):98-102
pubmed: 18632446
N Engl J Med. 2001 Apr 19;344(16):1222-31
pubmed: 11309638
Am J Med. 2003 Apr 1;114(5):421-2
pubmed: 12714139
Womens Health (Lond). 2016 Jul;12(4):433-41
pubmed: 27638899
Blood. 2013 May 9;121(19):3953-61
pubmed: 23550034
Am J Obstet Gynecol. 2006 May;194(5):1311-5
pubmed: 16647915
CMAJ. 2002 Jul 9;167(1):48-54
pubmed: 12137081
BMJ. 2017 Oct 26;359:j4452
pubmed: 29074563
Blood Transfus. 2012 Jul;10(3):257-9
pubmed: 22889815
Meta Gene. 2014 Jul 15;2:505-13
pubmed: 25606434
BMC Med Genet. 2019 Jan 5;20(1):2
pubmed: 30611230
Vasc Health Risk Manag. 2009;5(1):85-7
pubmed: 19436646